Effect of skin-capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 08 2021
Historique:
received: 08 05 2021
accepted: 19 07 2021
entrez: 3 8 2021
pubmed: 4 8 2021
medline: 6 11 2021
Statut: epublish

Résumé

The effect of the skin-capsular distance (SCD) on the controlled attenuation parameter (CAP) for diagnosis of liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. The SCD was measured using B-mode ultrasound, and the CAP was measured using the M probe of FibroScan

Identifiants

pubmed: 34341368
doi: 10.1038/s41598-021-94970-3
pii: 10.1038/s41598-021-94970-3
pmc: PMC8329228
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15641

Informations de copyright

© 2021. The Author(s).

Références

Hepatol Res. 2016 Sep;46(10):1019-27
pubmed: 27183219
Hepatology. 2008 Feb;47(2):380-4
pubmed: 18095306
J Viral Hepat. 2007 May;14(5):360-9
pubmed: 17439526
J Hepatol. 2010 Feb;52(2):206-10
pubmed: 20022130
J Hepatol. 2009 Dec;51(6):1061-7
pubmed: 19846234
Hepatology. 2018 Apr;67(4):1348-1359
pubmed: 29108123
J Gastroenterol Hepatol. 2013 Jul;28(7):1194-201
pubmed: 23425053
Pediatr Gastroenterol Hepatol Nutr. 2015 Jun;18(2):108-14
pubmed: 26157696
Hepatology. 2012 Nov;56(5):1751-9
pubmed: 22707395
Nutr Clin Pract. 2013 Feb;28(1):101-11
pubmed: 23042833
Diabetes Metab Syndr Obes. 2019 Jul 11;12:1105-1111
pubmed: 31372020
J Hepatol. 1986;2(2):165-73
pubmed: 3958472
Dig Dis Sci. 2015 Jan;60(1):243-51
pubmed: 25194851
Diagnostics (Basel). 2020 Nov 12;10(11):
pubmed: 33198092
Br J Radiol. 1979 Mar;52(615):184-8
pubmed: 435696
Liver Int. 2015 Nov;35(11):2392-400
pubmed: 25689614
JGH Open. 2019 Dec 17;4(3):497-502
pubmed: 32514460
Eur J Gastroenterol Hepatol. 2020 Feb;32(2):231-238
pubmed: 31464788
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
PLoS One. 2014 Jun 05;9(6):e98689
pubmed: 24901649
J Gastroenterol. 2012 Mar;47(3):293-9
pubmed: 22065161
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Hepatology. 2019 Jun;69(6):2672-2682
pubmed: 30179269
Gastroenterology. 2002 Nov;123(5):1705-25
pubmed: 12404245
World J Gastroenterol. 2014 Apr 28;20(16):4702-11
pubmed: 24782622
J Hepatol. 2012 May;56(5):1152-1158
pubmed: 22245892
J Pediatr Gastroenterol Nutr. 2021 Mar 1;72(3):430-435
pubmed: 33230078
Hepatology. 2008 Feb;47(2):592-5
pubmed: 18098325
Medicine (Baltimore). 2019 Nov;98(46):e17879
pubmed: 31725632
J Gastroenterol Hepatol. 2014 Jun;29(6):1149-58
pubmed: 24476011
Liver Int. 2014 Jan;34(1):102-9
pubmed: 24028214
Am J Gastroenterol. 1999 Sep;94(9):2467-74
pubmed: 10484010
J Gastroenterol. 2016 May;51(5):496-505
pubmed: 26463734
J Gastroenterol. 2020 Apr;55(4):428-440
pubmed: 31654131
Gastroenterology. 2005 Jun;128(7):1898-906
pubmed: 15940625
AJR Am J Roentgenol. 2007 Dec;189(6):W320-3
pubmed: 18029843
J Gastroenterol Hepatol. 2014;29(7):1470-6
pubmed: 24548002
Amyloid. 2011 Mar;18(1):19-24
pubmed: 21219116
Hepatology. 2008 Nov;48(5):1718-23
pubmed: 18836992
Gut. 2007 Sep;56(9):1330-1
pubmed: 17470477
Gastroenterology. 2017 Feb;152(3):598-607.e2
pubmed: 27911262
Eur J Radiol. 2013 Aug;82(8):e313-6
pubmed: 23562532
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Ultrasound Med Biol. 2010 Nov;36(11):1825-35
pubmed: 20870345

Auteurs

Syunichiro Kimura (S)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Kenichi Tanaka (K)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Satoshi Oeda (S)

Liver Center, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan. ooedasa@cc.saga-u.ac.jp.
Department of Laboratory Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan. ooedasa@cc.saga-u.ac.jp.

Kaori Inoue (K)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Chika Inadomi (C)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Yoshihito Kubotsu (Y)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Wataru Yoshioka (W)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Michiaki Okada (M)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Hiroshi Isoda (H)

Liver Center, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Takuya Kuwashiro (T)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Takumi Akiyama (T)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Aya Kurashige (A)

Department of Laboratory Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Ayaka Oshima (A)

Department of Laboratory Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Mayumi Oshima (M)

Department of Laboratory Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Yasue Matsumoto (Y)

Department of Laboratory Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Atsushi Kawaguchi (A)

Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Keizo Anzai (K)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Eisaburo Sueoka (E)

Department of Laboratory Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Shinichi Aishima (S)

Department of Pathology & Microbiology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Hirokazu Takahashi (H)

Liver Center, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH